KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to 0.52.

  • Aurinia Pharmaceuticals' Asset Utilization Ratio rose 2563.58% to 0.52 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52, marking a year-over-year increase of 2563.58%. This contributed to the annual value of 0.43 for FY2024, which is 2424.05% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Asset Utilization Ratio stood at 0.52, which was up 2563.58% from 0.52 recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Asset Utilization Ratio peaked at 0.52 during Q2 2025, and registered a low of 0.0 during Q1 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.28, with a median of 0.32 in 2023.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Asset Utilization Ratio soared by 1917224.54% in 2021 and then skyrocketed by 825.39% in 2023.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Asset Utilization Ratio stood at 0.1 in 2021, then surged by 176.82% to 0.28 in 2022, then grew by 13.86% to 0.32 in 2023, then soared by 34.34% to 0.43 in 2024, then rose by 20.72% to 0.52 in 2025.
  • Its last three reported values are 0.52 in Q3 2025, 0.52 for Q2 2025, and 0.47 during Q1 2025.